Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,806 | 4,757 | 12,049 | 17,525 | 3,286 |
| TOTAL | $42,137 | $11,712 | $13,623 | $19,073 | $4,668 |
| Non-Current Assets | |||||
| PPE Net | 483 | 107 | 75 | 65 | 67 |
| Other Non-Current Assets | 14 | 18 | 18 | 6 | 6 |
| TOTAL | $497 | $125 | $93 | $71 | $73 |
| Total Assets | $42,634 | $11,837 | $13,716 | $19,144 | $4,741 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,026 | 8,686 | 1,559 | 996 | 873 |
| Accrued Expenses | 558 | 2,009 | 2,874 | 1,836 | 111 |
| Other current liabilities | 10,717 | 14,803 | 10,908 | 6,756 | N/A |
| TOTAL | $17,301 | $25,498 | $15,341 | $9,588 | $984 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 931 | 0 | 0 | 0 | 0 |
| TOTAL | $198 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $17,499 | $25,498 | $15,341 | $9,588 | $984 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10 | 10 | 8 | 8 | 8 |
| Common Shares | 91 | 73 | 73 | 72 | 58 |
| Retained earnings | -133,797 | -127,023 | -113,400 | -101,042 | -94,562 |
| Other shareholders' equity | -733 | 0 | 0 | 0 | 0 |
| TOTAL | $25,135 | $-13,661 | $-1,625 | $9,556 | $3,757 |
| Total Liabilities And Equity | $42,634 | $11,837 | $13,716 | $19,144 | $4,741 |